At the IGTP TODAY

News

- Research

In vitro development of a new personalized therapy for patients with neurofibromatosis type 2

Researchers from the Clinical Genomics group of the Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service of the Germans Trias Hospital (HUGTiP) have developed a new in vitro therapy to recover part of the function encoded by the gene NF2, which, when altered, induces the development of neurofibromatosis type 2. The study has been published in the prestigious journal Molecular Therapy Nucleic Acids.

- Research

A study of more than 750 healthcare professionals confirms that antibodies persist 17 months after having suffered from COVID-19

  • Research has also confirmed that people who suffered from the disease in a serious way generate more antibodies than those who had moderate and mild effects.
  • The results of this study show significant differences in the generation of antibodies between men and women on day 30 of infection and for all antibodies measured.
  • This is one of the largest studies carried out to date in Catalonia, both in terms of the volume of participants and the length of follow-up.
- Conferences

The IGTP organizes the VI Interhospital Conference on Genetics in Catalonia

The VI Interhospital Conference on Genetics in Catalonia was held on Monday, organized by the Germans Trias i Pujol Hospital (HUGTiP) and Research Institute (IGTP). This annual event has been a meeting point for geneticists from a variety of Catalonia's hospitals and research centres since 2017. The main problems, advances and challenges of genetics future are shared and discussed.

- Campus Can Ruti

The IGTP hosts the EORTC Pathobiology Group (PBG) Annual Meeting

The European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group Annual Meeting took place on October 24 and 25, organized jointly by the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP). Over the two-day event, a series of talks on therapies to fight cancer were held both at the IGTP facilities and online.

- Research

A diet rich in plant-based omega-3 is associated with better outcomes in heart failure patients

Higher levels of plant-based omega-3 fats reduce the risk of death and hospital admission in people with heart failure. This is according to a joint study by researchers at Germans Trias i Pujol Hospital and Research Institute and the Hospital del Mar Medical Research Institute, published in the Journal of the American College of Cardiology, involving the follow-up of almost a thousand patients.